4//SEC Filing
Davis Todd C 4
Accession 0002001011-25-000029
CIK 0000886163other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 8:05 PM ET
Size
8.3 KB
Accession
0002001011-25-000029
Insider Transaction Report
Form 4
Davis Todd C
Director
Transactions
- Purchase
Common Stock
2025-05-09$104.57/sh+1,680$175,678→ 153,404 total - Purchase
Common Stock
2025-05-09$104.53/sh+2,307$241,150→ 155,711 total - Purchase
Common Stock
2025-05-09$105.67/sh+5,523$583,629→ 161,234 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $104.1300 to $105.1000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $105.1300 to $106.0000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001392029
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 8:05 PM ET
- Size
- 8.3 KB